DBV Technologies: Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 11/30/2024 | 102,847,501 | Total gross of voting rights: 102,847,501 |
Total net* of voting rights: 102,582,335 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$4.53 |
| Daily Change: | 0.47 11.58 |
| Daily Volume: | 292,704 |
| Market Cap: | US$92.960M |
January 08, 2025 December 11, 2024 November 06, 2024 October 22, 2024 September 23, 2024 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
